Blog

Here’s Why We’re Linking Claims with Our EHR Data. →

Every case of cancer tells us a story that can’t be captured on an intake form. At Flatiron Health, we’re helping researchers piece those stories together to unlock breakthroughs in cancer care.

Industry Insights

Using Machine Learning to Reimagine the Infrastructure of Cancer Care →

By Aaron Cohen, MD

Data Science

Getting to the Point (of Care) with Machine Learning →

By Shreyas Lakhtakia, Blythe Adamson, PhD, MPH

Achieving the impossible for rare populations: Leveraging technology to open opportunities for patients with hematologic malignancies

December 2022

Data Science

Here’s Why We’re Linking Claims with Our EHR Data.

By Sarah Brake, PhD, Susan Amlani

November 2022

Data Science

Getting to the Point (of Care) with Machine Learning

By Shreyas Lakhtakia, Blythe Adamson, PhD, MPH

September 2022

Data Science

Using Machine Learning to Reimagine the Infrastructure of Cancer Care

By Aaron Cohen, MD

July 2022

Industry Insights

Comment on Real-World Data: Assessing Electronic Health Records and Medical Claims Data to Support Regulatory Decision-Making for Drug and Biological Products

By Flatiron Health

November 2021

Industry Insights

Machine Learning and Cancer’s N of One

By Carolyn Starrett

November 2021

Industry Insights

Flatiron Health Comment on PDUFA VII Commitment Letter

By Flatiron Health

September 2021

Industry Insights

How Real-World Clinico-Genomic Data is Delivering New Cancer Insights

By Ethan Sokol, Tamara Snow

September 2021

Data Science

Real-World Data in Real Time: Early Lessons from the Covid-19 Pandemic

By Tim Showalter, MD, MPH, Rebecca Miksad, MD, MPH

June 2021

Industry Insights

Flatiron Health at the Reagan-Udall Foundation’s 2021 Public Annual Meeting

By Irene Nunes

May 2021

Industry Insights